https://www.ncbi.nlm.nih.gov/pubmed/31140156 NAFLD
Hormones (Athens). 2019 May 28. doi: 10.1007/s42000-019-00107-7. [Epub ahead of print]

Non-alcoholic fatty liver infiltration in children: an underdiagnosed evolving disease.

Tzifi F1,2, Fretzayas A3, Chrousos G4, Kanaka-Gantenbein C4.

Abstract

Non-alcoholic fatty liver disease (NAFLD) constitutes the most common liver disease, one that is still underdiagnosed in pediatric populations (as well as in the general population), this due to the progressive increase in childhood obesity observed both in developed and developing countries during the last few decades. The pathophysiology of the disease has not been thoroughly clarified yet. The condition displays common pathways in adults and children; however, there are age-related differences. Unlike adults, children with NAFLD require extensive laboratory analysis, because underlying pathologies other than obesity may contribute to the evolution of the disease. Despite the presence of several serum markers and imaging techniques that contribute to NAFLD diagnosis, liver biopsy remains the gold standard diagnostic procedure. Early intervention and obesity prevention are mandatory, as NAFLD is reversible at an early stage. If left undiagnosed and untreated, NAFLD can progress to steatohepatitis (NASH) and subsequent liver failure, a potentially lethal complication. Of note, there are no treatment options when advanced liver fibrosis occurs. This review summarizes literature data on NAFLD in childhood indicating that this is an evolving disease and a significant component of the metabolic syndrome. Pediatricians should be aware of this entity, screening childrenat high risk and providing appropriate early management, in collaboration with pediatric subspecialists.